InSingulo AB vs KSQ Therapeutics, Inc.

InSingulo AB logo

InSingulo AB

The right environment for drug discovery

11 employees · est. 2017 · Sweden

VS
KSQ Therapeutics, Inc. logo

KSQ Therapeutics, Inc.

The company is deploying CRISPRomics for novel drug development across broad therapeutic areas and is currently advancing a proprietary pipeline of tumor- and immune-focused drug candidates

60 employees · est. 2015 · Lexington, United States

KSQ Therapeutics, Inc. is the older company (2017 vs 2015); KSQ Therapeutics, Inc. is the larger of the two.

Side-by-Side Comparison

InSingulo AB KSQ Therapeutics, Inc.
Founded
2017 2015 older
Headquarters
Sweden Lexington, United States
Employees
11 60 larger
Industry
Biotechnology, Health Care, Life Sciences Biopharma, Biotechnology, Health and Wellness
Funding Stage
Seed Series C
Total Funding
Not tracked yet $166.00M
Funding Rounds
Not tracked yet 4
Services
Not tracked yet CRISPRomics Platform, Cancer Drug Development, Pipeline Advancements, Partnerships for Drug Development
Target Customers
Not tracked yet Healthcare Providers, Cancer Patients, Research Institutions, Pharmaceutical Companies
Taxonomy
Drug DiscoveryBiosensing TechnologyCharacterization Of Drug InteractionsMembrane ProteinsDrug ScreeningTherapeutic Targets +4 CRISPRomicsDrug DevelopmentFunctional GenomicsTumor-focused TherapiesImmune-focused TherapiesGenome-scale Precision +9
Website
insingulo.com ksqtx.com
InSingulo AB logo

About InSingulo AB

InSingulo AB is a biotechnology startup based in Sweden, founded in 2017. The company's slogan "The right environment for drug discovery" underscores their focus on providing an optimal setting for drug development. InSingulo specializes in the characterization of drug interactions with complex targ...

KSQ Therapeutics, Inc. logo

About KSQ Therapeutics, Inc.

KSQ Therapeutics, Inc. stands as a pioneering entity in the biopharmaceutical industry, leveraging its industry-leading CRISPRomics platform to revolutionize drug development. Based in Cambridge, Massachusetts, the company focuses on pinpointing therapeutic nodes that directly correlate genomic func...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches InSingulo AB and KSQ Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when InSingulo AB or KSQ Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

InSingulo AB was founded in 2017, based in Sweden, with 11 employees. InSingulo AB is a biotechnology startup based in Sweden, founded in 2017. The company's slogan "The right environment for drug discovery" underscores their focus on providing an optimal setting for dr. KSQ Therapeutics, Inc. was founded in 2015, based in Lexington, United States, with 60 employees. KSQ Therapeutics, Inc. stands as a pioneering entity in the biopharmaceutical industry, leveraging its industry-leading CRISPRomics platform to revolutionize drug development. Based in Cambridge, Mass.
InSingulo AB has raised no disclosed funding and KSQ Therapeutics, Inc. $166.00M. Latest stage: InSingulo AB Seed, KSQ Therapeutics, Inc. Series C.
Both work in Biotechnology.

Compare InSingulo AB with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at InSingulo AB on 12 Sep 2024, and KSQ Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes